Christine Peterson
Overview
Explore the profile of Christine Peterson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
462
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Brito-Dellan N, Franco-Vega M, Ruiz J, Lu M, Sahar H, Rajapakse P, et al.
Support Care Cancer
. 2024 Sep;
32(10):661.
PMID: 39283351
Purpose: Immune checkpoint inhibitor-related pneumonitis (ICI-P) is a condition associated with high mortality, necessitating prompt recognition and treatment initiation. This study aimed to assess the impact of implementing a clinical...
2.
Peterson C
Science
. 2024 Aug;
385(6711):817.
PMID: 39172832
The research uses aerial imagery to pinpoint structures that could block migratory pronghorn and other wildlife.
3.
Brito-Dellan N, Franco-Vega M, Ruiz J, Lu M, Sahar H, Rajapakse P, et al.
Res Sq
. 2024 Apr;
PMID: 38659939
Purpose: Immune checkpoint inhibitor-related pneumonitis (ICI-P) is a condition associated with high mortality, necessitating prompt recognition and treatment initiation. This study aimed to assess the impact of implementing a clinical...
4.
Court L, Aggarwal A, Jhingran A, Naidoo K, Netherton T, Olanrewaju A, et al.
JCO Glob Oncol
. 2024 Mar;
10:e2300376.
PMID: 38484191
Purpose: Increased automation has been identified as one approach to improving global cancer care. The Radiation Planning Assistant (RPA) is a web-based tool offering automated radiotherapy (RT) contouring and planning...
5.
He Y, Cazoulat G, Wu C, Svensson S, Almodovar-Abreu L, Rigaud B, et al.
Int J Radiat Oncol Biol Phys
. 2023 Aug;
118(1):231-241.
PMID: 37552151
Purpose: The aim of this study was to investigate the dosimetric and clinical effects of 4-dimensional computed tomography (4DCT)-based longitudinal dose accumulation in patients with locally advanced non-small cell lung...
6.
Gordon M, Jones J, George B, Peterson C, Burger J, Jain N, et al.
Cancer
. 2023 Apr;
129(14):2192-2200.
PMID: 37016930
Background: Continuous ibrutinib administration is needed to maintain efficacy in patients with chronic lymphocytic leukemia (CLL) and, as such, long-term toxicity is a concern. The authors report the 5-year follow-up...
7.
Coffin T, Bowen D, Swisher E, Lu K, Rayes N, Norquist B, et al.
JMIR Form Res
. 2022 Oct;
6(10):e34055.
PMID: 36251350
Background: Genetic testing uptake is low, despite the well-established connection between pathogenic variants in certain cancer-linked susceptibility genes and ovarian cancer risk. Given that most major insurers cover genetic testing...
8.
Coffin T, Bowen D, Lu K, Swisher E, Rayes N, Norquist B, et al.
JMIR Form Res
. 2022 Sep;
6(9):e35035.
PMID: 36155347
Background: Strong participant recruitment practices are critical to public health research but are difficult to achieve. Traditional recruitment practices are often time consuming, costly, and fail to adequately target difficult-to-reach...
9.
Qi X, Zhou S, Wang Y, Peterson C
Res Synth Methods
. 2022 Sep;
13(6):807-820.
PMID: 36054779
Meta-analysis allows researchers to combine evidence from multiple studies, making it a powerful tool for synthesizing information on the safety profiles of new medical interventions. There is a critical need...
10.
Babiker H, Schlegel P, Hicks L, Bullock A, Burhani N, Mahadevan D, et al.
Invest New Drugs
. 2021 Aug;
40(1):81-90.
PMID: 34417914
Background RX-3117 is an oral small molecule antimetabolite, cyclopentyl pyrimidyl nucleoside that is activated by cancer cells over-expressing uridine cytidine kinase 2 (UCK2). Single agent RX-3117 demonstrated efficacy in a...